Illicit Drug Use a Risk Factor for Ileal Mucormycosis Presenting With Acute Abdomen

Amaresh Aruni1, Cherring Tandup1, Anish Chowdhury1

  • 1Department of General Surgery, Post Graduate Institute of Medical Education and Research, Chandigarh, IND.

Cureus
|January 25, 2021
PubMed

Insights

This study reports a rare case of gastrointestinal mucormycosis in the ileum, successfully treated with surgery. Histopathology confirmed the fungal infection, highlighting its diagnostic importance.

Area of Science:

  • Mycology
  • Gastroenterology
  • Surgical Pathology

Background:

  • Mucormycosis is a rare, life-threatening fungal infection affecting immunocompromised individuals.
  • Commonly involves rhino cerebral, pulmonary, and cutaneous sites, with gastrointestinal involvement being less frequent.
  • Early diagnosis and treatment are crucial for patient outcomes.

Observation:

  • A rare case of gastrointestinal ileal mucormycosis presented with perforation peritonitis.
  • The patient underwent successful surgical management for the condition.
  • Histopathology of the surgical specimen revealed ileal mucormycosis with transmural necrotizing inflammation.

Findings:

  • Histopathological examination of surgical specimens is the gold standard for diagnosing mucormycosis.
  • This method is vital due to non-specific clinical symptoms and low fungal culture isolation rates.
  • Confirms the presence of angioinvasive fungal elements in tissue.

Implications:

  • Highlights the importance of considering mucormycosis in the differential diagnosis of abdominal emergencies, especially in at-risk populations.
  • Surgical intervention can be life-saving in cases of perforation.
  • Emphasizes the definitive role of histopathology in confirming rare fungal infections when other diagnostic methods are inconclusive.

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...